Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2012-07-20 (13 years)Status: ActiveBusiness sector: Commerce de gros (commerce interentreprises) de produits pharmaceutiquesLocation: PARIS (75018), Paris
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE BARBES : revenue, balance sheet and financial ratios
PHARMACIE BARBES is a French company
founded 13 years ago,
specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques.
Based in PARIS (75018),
this company of category PME
shows in 2023 a net income positive of 102 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE BARBES (SIREN 752952879)
Indicator
2023
2022
2021
2020
2018
2017
2016
2015
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
102 393 €
152 061 €
138 858 €
178 085 €
213 160 €
144 584 €
89 677 €
142 131 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2023, PHARMACIE BARBES generates positive net income of 102 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2015-2023: 142 k€ -> 102 k€.
Net income (2023)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
102 393 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 58%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 52%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2023)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
57.869%
Financial autonomy (2023)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
51.862%
Asset age ratio (2023)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2015
2016
2017
2018
2020
2021
2022
2023
Debt ratio
515.909
383.821
268.872
178.677
133.999
104.56
77.765
57.869
Financial autonomy
14.567
18.395
23.753
32.07
36.068
41.004
47.378
51.862
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
57.872023
2021
2022
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Average
In 2023, the debt ratio of PHARMACIE BARBES (57.87) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
51.86%2023
2021
2022
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Good+12 pts over 3 years
In 2023, the financial autonomy of PHARMACIE BARBES (51.9%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 178.77. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2023)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
178.769
Liquidity indicators evolution PHARMACIE BARBES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2015
2016
2017
2018
2020
2021
2022
2023
Liquidity ratio
201.86
188.668
177.038
222.978
207.158
204.833
205.153
178.769
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
178.772023
2021
2022
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Average-9 pts over 3 years
In 2023, the liquidity ratio of PHARMACIE BARBES (178.77) ranks below the median of the sector. This ratio measures the ability to cover short-term debt with current assets. An improvement would strengthen the competitive position.
Positioning of PHARMACIE BARBES in its sector
Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques
Valuation estimate
Based on 124 transactions of similar company sales
(all years),
the value of PHARMACIE BARBES is estimated at
84 117 €
(range 32 015€ - 307 186€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2023
124 transactions
32k€84k€307k€
84 117 €Range: 32 015€ - 307 186€
NAF 5 all-time
Valuation method used
Net Income Multiple
102 393 €
×
0.8x
=84 117 €
Range: 32 016€ - 307 186€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)
Compare PHARMACIE BARBES with other companies in the same sector:
The revenue of PHARMACIE BARBES is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE BARBES profitable?
Yes, PHARMACIE BARBES generated a net profit of 102 k€ in 2023.
Where is the headquarters of PHARMACIE BARBES ?
The headquarters of PHARMACIE BARBES is located in PARIS (75018), in the department Paris.
Where to find the tax return of PHARMACIE BARBES ?
The tax return of PHARMACIE BARBES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE BARBES operate?
PHARMACIE BARBES operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart